These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 27194998)
21. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation. Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451 [TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826 [TBL] [Abstract][Full Text] [Related]
23. Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: a case-control study. Sliem H; Tawfik G; Moustafa F; Zaki H Indian J Endocrinol Metab; 2011 Apr; 15(2):105-9. PubMed ID: 21731867 [TBL] [Abstract][Full Text] [Related]
24. FGF23: its role in renal bone disease. Fukagawa M; Kazama JJ Pediatr Nephrol; 2006 Dec; 21(12):1802-6. PubMed ID: 16932898 [TBL] [Abstract][Full Text] [Related]
25. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis. Gutiérrez OM Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957 [TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor 23 and the future of phosphorus management. Wolf M Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):463-8. PubMed ID: 19770756 [TBL] [Abstract][Full Text] [Related]
28. Longitudinal Study to Find the Association of Serum Phosphorus Level with FGF23 in Three Different Hyperphosphatemia Management Groups of Stage 3 and 4 Chronic Kidney Disease (CKD) Patients. Mahapatra HS; Kaur N; Sharma N; Pursnani L; Kumar M; Inamdar N; Singh M; Arora T Indian J Nephrol; 2022; 32(6):574-581. PubMed ID: 36704588 [TBL] [Abstract][Full Text] [Related]
29. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276 [TBL] [Abstract][Full Text] [Related]
30. Forging forward with 10 burning questions on FGF23 in kidney disease. Wolf M J Am Soc Nephrol; 2010 Sep; 21(9):1427-35. PubMed ID: 20507943 [TBL] [Abstract][Full Text] [Related]
31. High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4. Tsai MH; Leu JG; Fang YW; Liou HH Medicine (Baltimore); 2016 Mar; 95(11):e3049. PubMed ID: 26986127 [TBL] [Abstract][Full Text] [Related]
32. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. Moe SM; Radcliffe JS; White KE; Gattone VH; Seifert MF; Chen X; Aldridge B; Chen NX J Bone Miner Res; 2011 Nov; 26(11):2672-81. PubMed ID: 21826734 [TBL] [Abstract][Full Text] [Related]
33. FGF23 in chronic kidney disease. Wahl P; Wolf M Adv Exp Med Biol; 2012; 728():107-25. PubMed ID: 22396166 [TBL] [Abstract][Full Text] [Related]
34. Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23). van Helden J; Weiskirchen R Scand J Clin Lab Invest; 2018; 78(7-8):584-590. PubMed ID: 30380963 [TBL] [Abstract][Full Text] [Related]
35. Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate. Pavik I; Jaeger P; Kistler AD; Poster D; Krauer F; Cavelti-Weder C; Rentsch KM; Wüthrich RP; Serra AL Kidney Int; 2011 Jan; 79(2):234-40. PubMed ID: 20944552 [TBL] [Abstract][Full Text] [Related]
36. Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease. Felsenfeld AJ; Levine BS; Rodriguez M Semin Dial; 2015; 28(6):564-77. PubMed ID: 26303319 [TBL] [Abstract][Full Text] [Related]